The Pathobyte Series: Yersinia pestis- A Famed Foe

Yersinia pestis

Yersinia pestis is a versatile Gram-negative bacterium capable of causing the historically devastating disease known as plague. Driven by highly adaptive pathogenic mechanisms and severe virulence, it effortlessly evades host immunity, spreading rapidly through infected flea bites and respiratory droplets. Infections range from painful lymphatic swelling in bubonic plague to life-threatening systemic conditions, including septicemic and pneumonic forms. Accurate diagnosis leverages classic laboratory blood cultures and modern tools like PCR protocols and serological assays. While treatment typically requires immediate antibiotic therapy with agents like streptomycin or gentamicin, robust prevention relies heavily on rodent control and post-exposure prophylaxis.

History and naming

Yersinia pestis is well known by most for being one of the most important disease-causing agents in human history. Y. pestis causes the “plague”- outbreaks of which have inspired mythology, superstition, and finally advancements of medical microbiology. Three major plagues have been documented, with several other historical but unconfirmed mentions. The first plague is known as the ‘Justinian plague,’ which broadly went on between the middle 6th to 8th century across the Mediterranean Basin and Europe, named after Justinian I, the Roman emperor under whose rule it began.

The second pandemic, and perhaps the most widely known, raged between the late 1330s and the late 1830s- starting in Central Asia and washing over Europe. The first wave, lasting 7 years, is estimated to have caused the death of between one-fourth and one-third of humanity, and is dubbed in modernity ‘The Black Death’. This pandemic had a long-ranging and last impact on the historical and socio-cultural landscape of human history.

The third pandemic is difficult to separate temporally from the second, originating in 1772 in southwestern China, and went on to wreak destruction in all continents, spreading through new steamboat and railway routes. An important and defining event of the third plague occurred in Hong Kong in 1894. Physician Alexandre Yersin and bacteriologist Shibasaburo Kitasato, working separately, found the bacteria causative of the plague. Yersin’s superior characterisation earned him the reputation of being the discoverer of this bacteria, and he went on to develop an antiserum with his colleagues at the Pasteur Institute, which reduced mortality in affected populations. He named the causative bacteria Pasteurella pestis, and in 1970, it was renamed Yersinia pestis in his honour. It would, however, take many more years for plague to loosen its grip on the world.

Between 1900 and 1909, India suffered millions of deaths due to plague, and numbers lowered when effective measures came into effect. Vietnam in wartime, 1965-1975, suffered almost 30,000 cases. Africa followed in the 1980s, and it is still currently the continent with the highest burden of plague. In 2005, the plague stopped being a WHO-notifiable disease, an outcome of more than a hundred years of developing detection methods, protocols, and finding more effective treatments. Plague remains in the 21st century, but the scale of its effects has been vastly reduced. The 3 most endemic countries for plague are currently Madagascar, Peru, and the Democratic Republic of Congo, as reported by the WHO. 

Plague- A severe, highly infectious, and historically devastating disease caused by the bacterium Yersinia pestis, typically transmitted to humans through flea bites or infected rodents.

Pandemic- A massive, worldwide outbreak of an infectious disease that spreads rapidly across multiple countries and continents at the same time.

Bacteriologist- A specialized scientist who studies the growth, structure, behavior, and genetics of bacteria, particularly how they cause or prevent diseases.

Antiserum- A blood serum rich in pre-made antibodies taken from an immune human or animal, used to provide immediate, temporary protection or treatment against a specific germ.

Disease Caused

As discussed, the bacterium Yersinia pestis causes the plague. Multiple forms exist: bubonic, septicemic, and pneumonic. Meningitis and pharyngitis are rarer forms. 

Bubonic- The most common form of plague, characterized by painfully swollen, fluid-filled lymph nodes called "buboes," usually located in the groin, armpits, or neck.

Septicemic- An incredibly dangerous form of plague that occurs when the bacteria multiply directly within the bloodstream, causing widespread tissue decay and internal bleeding.

Meningitis- A severe, life-threatening inflammation of the protective fluid and three-layered membranes (meninges) that shield the brain and spinal cord.

Pharyngitis- Sudden inflammation or swelling of the throat (pharynx), causing painful soreness, redness, and severe difficulty when swallowing.

Transmission

Y. pestis is transferred by infected blood-sucking fleas, usually to rodents. Thus, bites from infected rodents or directly from infected fleas can spread this pathogen to the bloodstream of humans. Larger carnivores that prey on affected rodents may also contribute to the spread of plague. Pneumonic forms of plague can spread by droplets from respiratory symptoms, and other forms can spread through contact with infected tissue.

Pneumonic forms of plague- The most severe and lethal form of plague, occurring when the bacteria infect the lungs, causing an aggressive pneumonia that can spread easily from person to person through the air.

Yersinia pestis has dark ends under Wright’s stain, giving it a characteristic ‘safety pin’ appearance.

Signs and Symptoms

Bubonic plague is the most common form and is caused by a carrier flea bite. After 2-8 days of incubation, the patient experiences fever, chills, and fatigue, followed by lymphatic swelling and pain- known as “bubos”. Septicemic plague is similar, but is not associated with bubo development. Pneumonic plague can be a secondary infection from the bubo, or acquired (more rarely) as a primary infection after exposure to another infected person with respiratory symptoms.

Incubation- The silent timeframe between a person's initial exposure to a harmful germ and the exact moment they start showing the first physical symptoms of the illness.

Lymphatic swelling- The painful enlargement and inflammation of the lymph nodes as the immune system rushes white blood cells there to trap and fight an invading infection.

Diagnosis

Yersinia pestis infections are diagnosed mainly by isolation and identification of the bacteria in culture. According to the CDC, blood cultures are sensitive and can be used to confirm a plague diagnosis. In the case of high suspicion and a negative culture test, serological assays can be used additionally, which involve the detection of a specific F1 antigen. In field applications, PCR protocols are sometimes used.

Culture test- A conventional laboratory technique where a patient's sample is placed in a warm, nutrient-rich environment to encourage germs to grow so they can be identified.

Serological assays- Diagnostic blood tests that analyze a patient's serum to detect the specific antibodies or antigens produced during an active immune response to an infection.

Specific F1 antigen- A unique, signature protein found on the outer capsule of Yersinia pestis that laboratory technicians look for to definitively identify a case of the plague.

PCR- A highly precise lab technique that acts like a molecular copy machine, making millions of copies of a germ's DNA so it can be instantly recognized.

Treatment

Modern plague treatments come in the form of antibiotic therapy. This must be done ideally within 24 hours, requiring fast and accurate identification once symptoms start. Streptomycin and gentamicin are commonly used for the treatment of plague in adults and children (with appropriately lowered dosage). Another option is a combination of chloramphenicol, ciprofloxacin, and doxycycline. Based on regulations, treatment plans may vary slightly based on individual countries. Besides antimicrobial treatment for disease clearance, it may also be beneficial to treat severe symptoms of the plague, like shock. 

Antibiotic therapy- A medical treatment protocol that uses targeted prescription medications (antibiotics) to kill or stop the growth of dangerous bacteria inside the body.

Streptomycin- A powerful, classic aminoglycoside antibiotic administered intravenously as a primary, frontline treatment to eradicate severe plague infections.

Gentamicin- A strong, broad-spectrum injectable antibiotic frequently used by doctors to treat highly dangerous, complicated bacterial infections throughout the body.

Chloramphenicol- A potent antibiotic capable of deep tissue penetration, making it highly effective at treating severe infections that have breached the brain or nervous system.

Ciprofloxacin- A versatile, widely prescribed antibiotic used to prevent or treat a broad variety of systemic bacterial illnesses, including respiratory infections.

Doxycycline- A common, long-acting antibiotic pill frequently used to treat standard bacterial infections or prescribed as an immediate preventative shield after germ exposure.

Antimicrobial treatment- A broad category of medical care utilizing drugs (like antibiotics, antivirals, or antifungals) to kill or halt the spread of various disease-causing microbes.

Prevention

Since bubonic plague is spread mainly by rodents, the main route for prevention is to avoid contact with rodents, especially in areas of known plague occurrence. Care must be taken to avoid exposure to fleas, which carry Y. pestis, by using insect repellent, and using appropriate protective gear and clothing when outdoors, and applying insecticides to tents and bedding if any. It is also recommended to avoid handling animal carcasses and using protective equipment if required. Pneumonic plague can spread from an infected person through droplets, and cases must be isolated with appropriate measures to ensure the infection is not passed on, as well as equipping anyone in contact with the patient with masks, gloves, gowns, and eye coverings. So far, an effective plague vaccine has not been found, though historically, vaccines have been used to reduce mortality during certain outbreaks. 

Post-exposure prophylaxis, i.e., preventing exposure from progressing to disease, should be given in the form of antibiotics to those who have been exposed to Y. pestis- the bacteria itself, infected fleas or animals, or if they have been in contact with pneumonic plague-affected individuals. 

On a broader level, care must be taken to avoid providing food and shelter to feral rodents, such as waste food, garbage, and piles of material. Pet animals should be regularly checked and treated for fleas. Strategic testing and monitoring of local carnivores (that may acquire the disease after eating smaller animals) and rodent populations can help estimate risks and the presence of plague. Upon outbreaks, rat populations must be appropriately culled, and proper control of fleas must be done. 

Carcasses- The dead bodies of animals, which can act as highly infectious environmental reservoirs if the animal died from a contagious disease.

Vaccines- Biological preparations containing safe, dead, or weakened parts of a germ designed to proactively train the immune system to recognize and destroy future infections.

Prophylaxis- A preventative medical strategy, such as taking a short course of targeted antibiotics, used to stop a disease from taking root after a person has been exposed to a germ.

Microbe Profile 

Gram status: -ve

Shape: Bacillus/ Coccobacillus

Spore formation: No

Motile: No

Optimum temperature: 28-30 degrees Celsius

Optimum pH: 7.4

Taxonomy 

Domain: Bacteria

Kingdom: Pseudomonadati

Phylum: Pseudomonadota

Class: Gammaproteobacteria

Order: Enterobacterales

Family: Yersiniaceae

Genus: Yersinia

Species Group: Yersinia pseudotuberculosis complex

-Antara Arvind

Reference

Barbieri, R., Signoli, M., Chevé, D., Costedoat, C., Tzortzis, S., Aboudharam, G., Raoult, D., & Drancourt, M. (2020). Yersinia pestis: the Natural History of Plague. Clinical Microbiology Reviews, 34(1). https://doi.org/10.1128/cmr.00044-19

Butler, T. (2014). Plague history: Yersin’s discovery of the causative bacterium in 1894 enabled, in the subsequent century, scientific progress in understanding the disease and the development of treatments and vaccines. Clinical Microbiology and Infection, 20(3), 202–209. https://doi.org/10.1111/1469-0691.12540

Clinical testing and diagnosis for plague. (2024, May 15). Plague. https://www.cdc.gov/plague/hcp/diagnosis-testing/?CDC_AAref_Val=https://www.cdc.gov/plague/healthcare/clinicians.html

Dillard, R. L., & Juergens, A. L. (2023, August 7). Plague. StatPearls - NCBI Bookshelf. https://www.ncbi.nlm.nih.gov/books/NBK549855/

Ditchburn, J., & Hodgkins, R. (2019). Yersinia pestis, a problem of the past and a re-emerging threat. Biosafety and Health, 1(2), 65–70. https://doi.org/10.1016/j.bsheal.2019.09.001

Epidemic and Pandemic Preparedness and Prevention (EPP). (2024, September 25). Manual for plague surveillance, diagnosis, prevention and control. https://www.who.int/publications/i/item/9789240090422

Nyenke, C. U., Esiere, R. K., Nnokam, B. A., & Nwalozie, R. (2023). Plague: symptoms, transmission, diagnosis, prevention and treatment. South Asian Journal of Research in Microbiology, 16(1), 10–16. https://doi.org/10.9734/sajrm/2023/v16i1297

World Health Organization: WHO. (2019, November 1). Plague. https://www.who.int/health-topics/plague#tab=tab_1

Yang, R. (2017a). Plague: recognition, treatment, and prevention. Journal of Clinical Microbiology, 56(1). https://doi.org/10.1128/jcm.01519-17

Yang, R. (2017b). Plague: recognition, treatment, and prevention. Journal of Clinical Microbiology, 56(1). https://doi.org/10.1128/jcm.01519-17

Yersin, B. W. A. (2010). Etymologia: Yersinia. Emerging Infectious Diseases, 16(3), 496. https://doi.org/10.3201/eid1603.et1603

Frequently Asked Questions

What distinguishes the symptoms of bubonic plague from the septicemic form?

Bubonic plague is characterized by the painful development of swollen, fluid-filled lymph nodes called buboes following an infected flea bite. In contrast, the highly dangerous septicemic form multiplies directly within the bloodstream without causing these characteristic localized swellings.

Who discovered the bacterium responsible for the plague, and what was its original name?

Alexandre Yersin and Shibasaburo Kitasato independently found the bacterium in 1894, with Yersin receiving primary credit for his superior characterization. He originally named the pathogen Pasteurella pestis before it was officially renamed in his honor in 1970.

How does pneumonic plague differ from other forms in its route of transmission?

While bubonic and septicemic plague rely on blood-sucking flea bites or direct contact with infected animal tissues, the pneumonic form targets the respiratory system. This highly lethal variant spreads easily between humans through aerosolized droplets released during coughing or sneezing.

How do medical laboratories definitively diagnose an active infection caused by Yersinia pestis?

Laboratories primarily isolate the bacteria using sensitive blood culture tests to confirm a definitive diagnosis. If cultures are negative but suspicion remains high, technicians use molecular PCR protocols or serological assays that detect the specific F1 antigen.

What is the standard protocol for treating the plague, and why is timing so critical?

Treatment requires immediate antibiotic therapy using targeted medications like streptomycin, gentamicin, or combinations including doxycycline. These antimicrobial treatments must ideally begin within 24 hours of symptom onset to effectively clear the pathogen and prevent fatal shock.

BugSpeaks®

BugSpeaks®, developed by Leucine Rich Bio Pvt Ltd, South Asia’s first microbiome company, is headquartered in Bengaluru, India. Since 2014, the company has pioneered advanced analytics to analyze complex genomics data. Collaborating with leading research institutes globally, Leucine Rich Bio has leveraged its expertise to create BugSpeaks®, South Asia’s first gut microbiome test.